Search

everythinglearnresearchcommunity

for

Search:↓

The conclusion is that we need more effective hair loss treatments than the current ones, and these could include new drugs, gene and stem cell therapy, hormones, and scalp cooling, but they all need thorough safety testing.

Biologic treatments for Crohn's disease and ulcerative colitis can cause skin problems, and doctors should adjust treatment if these occur.

Transplant patients on immunosuppressive medications have a higher risk of skin cancer, and managing this involves balancing medication with cancer risk.

Frontal Fibrosing Alopecia needs better diagnostics and treatments, with dutasteride showing promise.

Apremilast shows promise for several skin conditions but needs more research.

Pharmacists play a crucial role in improving patient outcomes through personalized care and staying updated with scientific advancements.

Purpura fulminans can signal underlying autoimmune disorders, not just infections.

Atypical symptoms in lupus can indicate different kidney issues.

Stopping certain drugs can improve skin conditions, arsenicosis affects over half of a Bangladeshi village, males are more vulnerable, and certain treatments are effective for warts, acne, and psoriasis. Smoking and drinking are linked to psoriasis in men, a cream helps with a type of skin cancer, and low iron levels don't directly cause chronic hair loss in women.

Nanoparticulate systems improve drug delivery by controlling release, protecting drugs, changing absorption and distribution, and concentrating drugs in targeted areas.

A 10-year-old girl with Fox Fordyce disease improved with treatment, suggesting the disease can occur before puberty and might be underdiagnosed in young girls.

Tofacitinib nanoparticles can safely and effectively treat alopecia areata by targeting hair follicles.

Fox Fordyce disease can occur in prepubertal girls and may be underdiagnosed.

The cat's skin condition improved significantly with medication, with no relapse.

Vitiligo treatment requires a personalized mix of therapies to restore skin color and improve life quality.

The microbiome may be linked to hair loss and could be a target for new treatments.

Up to 50% of women may experience significant hair loss by age 50, with various causes and treatments available.

Cyclosporin A and FK506 can start new hair growth without needing immunosuppression.

Biologics, especially Dupilumab, are effective and safe for treating severe childhood eczema.

JAK inhibitors and platelet-rich plasma show promise for treating alopecia areata.

Tofacitinib helped regrow hair in patients with alopecia, with few side effects.

Tacrolimus can cause hair loss in kidney transplant patients.

Anifrolumab significantly improved skin lesions and hair regrowth in severe discoid lupus.

A rare skin condition was confirmed to be associated with a specific virus in a young girl.

More research is needed to understand and treat morphea effectively.

A new microneedle patch effectively promotes hair regrowth with less frequent dosing.

Baricitinib effectively treated hair loss and inflammation in a patient with alopecia areata and lichen planopilaris.

Allergen-specific immunotherapy can significantly improve hair loss and dermatitis symptoms in severe cases.

Improved oral hygiene and dietary changes can help manage black hairy tongue syndrome.

The combined treatment helps improve severe hair loss and reduces the need for other medications.